Development of anti-inflammatory drugs by targeting vesicular traffic in dendritic cells
| Project/Area Number |
25670460
|
|---|
| Research Category |
Grant-in-Aid for Challenging Exploratory Research
|
| Allocation Type | Multi-year Fund |
|---|
| Research Field |
Collagenous pathology/Allergology
|
|---|
| Research Institution | Kagawa University (2015)
Kyoto University (2013-2014) |
|---|
Principal Investigator |
|
|---|
| Co-Investigator(Renkei-kenkyūsha) |
ISHIHAMA Yasushi 京都大学, 大学院薬学研究科, 教授 (30439244)
|
|---|
| Project Period (FY) |
2013-04-01 – 2016-03-31
|
| Project Status |
Completed (Fiscal Year 2015)
|
| Budget Amount *help |
¥3,640,000 (Direct Cost: ¥2,800,000、Indirect Cost: ¥840,000)
Fiscal Year 2014: ¥1,950,000 (Direct Cost: ¥1,500,000、Indirect Cost: ¥450,000)
Fiscal Year 2013: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
|
|---|
| Keywords | 樹状細胞 / I型インターフェロン / 小胞輸送 / キナーゼ |
|---|
| Outline of Final Research Achievements |
Plasmacytoid dendritic cells (pDC) produce a vast amount of IFN-alpha by recognizing exogenous DNA through TLR9, and provoke autoimmune and inflammatory disorders. A multi-kinase inhibitor dasatinib suppresses the IFN-alpha production by pDC. To identify the responsible kinases and their substrates, we used various kinase inhibitors and mRNA knockdown, and selected 3 kinases as candidate kinases.
|
Report
(4 results)
Research Products
(10 results)
-
-
-
-
-
-
-
[Presentation] がん免疫療法の進歩2015
Author(s)
門脇則光
Organizer
第59回日本輸血・細胞治療学会近畿支部総会
Place of Presentation
枚方
Year and Date
2015-10-28
Related Report
Invited
-
-
-
